Neurofilaments in health and disease

Medical Electron Microscopy

Volumn 33, Issue 4, 2000, Pages 173-199

  Gotow, T ^a  

^a KOSHIEN UNIVERSITY   (Japan)

Author keywords

Aluminum treated rabbit; Crossbridge; Mutant mice; Neurodegenerative disease; Phosphorylation of neurofilament H (NF H) protein; Transgenic mice

Indexed keywords

ALUMINUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENDRITE; GENE DISRUPTION; GENE OVEREXPRESSION; MOUSE; NERVE FIBER; NEUROFILAMENT; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; TETANIC SPASM; TRANSGENIC MOUSE;

ALUMINUM; ANIMALS; CELL DEATH; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENTS; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; NEUROFILAMENT PROTEINS; NEURONS; PHOSPHORYLATION; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034438296     PISSN: 09184287     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007950000019     Document Type: Review

References (119)

1. Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton
2. Neurofilament protein phosphorylation - Where, when and why
3. Neurofilament proteins
4. Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments
5. Dynamic structure and function of neurofilaments
6. Structure of peripheral domains of neurofilaments revealed by low angle rotary shadowing
7. Macromolecular structure of reassembled neurofilaments as revealed by the quick-freeze deep-etch mica method: Difference between NF-M and NF-H subunits in their ability to form cross-bridges
8. Regulation of neurofilament interactions in vitro by natural and synthetic polypeptides sharing Lys-Ser-Pro sequences mith the heavy neurofilament subunit NF-H: Neurofilament crossbriging by antipallel sidearm over lapping
9. Dephosphorylation of the largest neurofilament subunit protein influences the structure of crossbridges in reassmbled neurofilaments
10. Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments
11. Neurofilaments are obligate heteropolymers in vivo
12. Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: Cross-bridge formation and longitudinal elongation of filaments
13. Neurofilament (NF) assembly: Divergent characteristics of human and rodent NF-L subunits
14. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ
15. Biochemical and immunocytochemical characterization and distribution of phosphorylated and nonphosphorylated subunits of neurofilaments in squid giant axon and stellate ganglion
16. The organization of neurofilaments accumulated in perikaryon following aluminum administration: Relationship between structure and phosphorylation of neurofilaments
17. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease
18. Phosphorylation of neurofilament proteins and chromatolysis following transection of rat sciatic nerve
19. Neuofilament abnormalities in motor neurons in spontaneously occurring animal disoders
20. Neurofilament antigens in acrylamide neuropathy
21. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis
22. The expression of phosphorylated neurofilament epitopes in human brains
23. Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis
24. Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam
25. Regulation of aberrant neurofilament phosphorylation in neuronal perikarya. I. Production following colchicine application to the sciatic nerve
26. Regulation of aberrant neurofilament phosphorylation in neuronal perikarya. II. Correlation with continued axonal elongation following axotomy
27. Experimental production of neurofibrillary degeneration. I. Light microscopic observations
28. Experimental production of neurofibrillary degeneration. 2, Electron microscopy, phosphatase histochemistry and electron probe an analysis
29. Phosphorylation of neurofilaments is altered in aluminium intoxication
30. Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum
31. Aluminum salts induce the accumulation of neurofilaments in perikarya of NB2a/dl neuroblastoma
32. Neuronal cytoskeletal lesions induced in the CNS by intraventricular and intravenous aluminum maltol in rabbits
33. Aluminum induces the in vitro aggregation of bovine cytoskeletal proteins
34. Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes
35. Effect of aluminum and other multivalent cations on neurofilaments in vitro: An electron microscopic study
36. A molecular mechanism for the induction of neurofilament bundling by aluminum ions
37. Aluminum alters the electrophoretic properties of neurofilament proteins: Role of phosphorylation state
38. A molecular mechanism of aluminum neurotoxicity. Reply
39. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
40. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease
41. Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons
42. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein
43. Subcellular compartmentalization of phosphorylated neurofilament polypeptides in neurons
44. Phosphorylation of neurofilament proteins in intact neurons: Demonstration of phosphorylation in cell bodies and axons
45. Properties of highly viscous gels formed by neurofilaments in vitro. A possible consequence of a specific inter-filament cross-bridging
46. Influence of the phosphorylation state of neurofilament proteins on the interactions between purified filaments in vitro
47. Neurofilament phosphorylation: A new look at regulation and function
48. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by cdk5 and p35
49. Dephosphorylation-induced interactions of neurofilaments with microtubules
50. Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules
51. Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns
52. Posttranslational modification of neurofilament polypeptides in rabbit retina
53. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells
54. The effects of dephosphorylation in the structure of the projections of neurofilament
55. Mitochondria and apoptosis
56. Bcl-2 family proteins regulate the release of apoptotic cytochrome c by the mitochondrial channel VDAC
57. Bcl-2 family: Life-or-death switch
58. Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cells
59. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
60. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice
61. A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease
62. Disruption of NF-H gene increases axonal microtubule content and velocity of neurofilament transport: Relief of axonopathy resulting from the toxin β,β′-iminodipropionitrile
63. Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport
64. Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice
65. Axonal transection in the lesions of multiple sclerosis
66. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons
67. An AG-GG transition at a splice site in the myelination proteolipid protein gene in jimpy mice results in the removal of an exon
68. A single nucleotide difference in the gene for myelin proteolipid protein difines the jimpy mutation in mouse
69. Ultrastructure of the central nervous system in a myelin deficient rat
70. Immunohistochemical localization of 2′,3′-cyclic nucleotide 3′-phosphodiesterase and myelin basic protein in the central nervous system of the jimpy and the normal mouse
71. Oligodenedroglial cell death in jimpy mice: An explanation for the myelin deficit
72. Abnormal expression of neurofilament proteins in dysmyelinating axons located in the central nervous system of jimpy mutant mice
73. Neurological mouse mutants and the genes of myelin
74. Glutamate slows axonal transport of neurofilaments in transfected neurons
75. Pathologic changes in the CNS of dystonia musculorum mutant mouse: An animal model for human spinocerebellar ataxia
76. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
77. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation
78. Pathogenesis of two axonopathies does not require axonal neurofilaments
79. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant
80. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments
81. Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene
82. Hereditary hypotrophic axonopathy with neurofilament deficiency in a mutant strain of the Japanese quail
83. Defective expression of neurofilament protein subunits in hereditary hypotrophic axonopathy of quail
84. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail
85. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
86. Aberrant neurofilament phosphorylation in Alzheimer disease
87. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls
88. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
89. Aluminum-induced neurofibrillary changes in axons and dendrites
90. Aluminum neurotoxicity: Altered expression of cytoskeletal genes
91. Neuronal gene expression in aluminum myelopathy
92. Aluminum-induced neurofilamentous changes in cultured rat dorsal root ganglia explants
93. Selective messenger RNA reduction in Alzheimer's disease
94. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons
95. Alterations in neurofilament mRNA in hereditary canine spinal muscular atrophy
96. Axonal atrophy in aging is associated with a decline in neurofilament gene expression
97. Neurofilaments run sprints not marathons
98. Rapid movement of axonal neurofilaments interrupted by prolonged pauses
99. Neurofilaments and motor neuron disease
100. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis
101. Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation
102. Requirement of heavy neurofilament subunit in the development of axons with large calibers
103. Progressive hyperphosphorylation of neurofilament heavy subunits with aging: Possible involvement in the mechanism of neurofilament accumulation
104. Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content
105. Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit
106. Neuroaxonal dystrophy in aging human sympathetic ganglia
107. Neurofilaments of aged rats: The strengthened interneurofilament interraction and the reduced amount of NF-M
108. Overexpression of neurofilament subunit M accelerates axonal transport of neurofilaments
109. Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits
110. Intermediate filaments on the move
111. Slow axonal transport of neurofilament proteins: Impairment by β,β′-iminodipropionitrile administration
112. Studies of neurofilaments that accumulate in proximal axons of rats intoxicated with β,β′-iminodipropionitrile (IDPN)
113. Effect of changes in neurofilament content on caliber of small axons: The β,β′-iminodipropionitrile model
114. Effect of a single dose of β,β′-iminodipropionitrile in vivo on the properties of neurofilaments in vitro: Comparison with the effect of iminodipropionitrile added directly to neurofilaments in vitro
115. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis
116. Swellings of proximal axons in a case of motor neuron disease
117. Motor neurons are rich in non-phosphorylated neurofilaments: Cross-species comparison and alterations in ALS
118. Subunit composition of neurofilaments specifies axonal diameter
119. Early effects of β,β′-iminodipropionitrile on tubulin solubility and neurofilament phosphorylation in the axon